Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern describe keratoconus, risk factors associated with the disease, and key parameters of keratoconus progression. They discuss the incidence and prevalence of keratoconus with various patient groups, as well as the standard diagnostic test criteria that should be used to identify keratoconus patients.
This activity is supported by an unrestricted educational grant from Avellino.
Upon completion of this activity, the participant should be able to:
This video has no credit associated with it.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
S. Barry Eiden, OD, FAAO
Program Director
President and Medical Director
North Suburban Vision Consultants
Deerfield, Illinois
Co-founder of the International
Keratoconus Academy of
Eye Care Professionals
Melissa Barnett, OD, FAAO, FSLS, FBCLA
Principal Optometrist
University of California, Davis, Eye Center
Sacramento, CA
Mile Brujic, OD, FAAO
Partner
Premier Vision Group
Bowling Green, OH
Gloria Chiu, OD, FAAO
Associate Professor of Clinical
Ophthalmology
USC Roski Eye Institute
University of Southern California
Keck School of Medicine
Los Angeles, CA
John D. Gelles, OD
Director
Specialty Contact Lens Division
Cornea and Laser Eye Institute (CLEI)
and the CLEI Center for Keratoconus
Teaneck, New Jersey
Assistant Clinical Professor
Rutgers New Jersey Medical School
Newark, NJ
Andrew S. Morgenstern, OD, FAAO
Vision Center of Excellence
Walter Reed National Military
Medical Center
Bethesda, Maryland
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
S. Barry Eiden, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Speaker’s Bureau: Avellino, Glaukos, Oculus, and Oprovve. Grant/Research Support: Oculus.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Advisory Board: Azura, Bruder, Cooper Vision, Dompe, Everyday Contacts, EyeEco, Mojo Vision, Novartis, Ocusoft, Oyster Point, Percept, and Raayonnova. Advisory Board/Consultant: Visus Therapeutics. Advisory Board/Speaker's Bureau: AAB, Acculens, Allergan, Bausch + Lomb, Contamac, Gas Permeable Lens Institute, JJVC Vistakon, RVL Pharmaceuticals, Scleral Lense Education Society, Synergeyes, Tangible Science, Tarsus. Speaker's Bureau: BCLA, Science Based Health, Sjogren's Syndrom Foundation, and STAPLE Program.
Mile Brujic, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Akorn, Alcon Vision, Allergan, Bausch + Lomb Health, Blephex, Contamac, CSEye, Eyevance, Horizon Therapeutics, Kala Pharmaceuticals, Novartis, Sun Pharmaceutical Industries, VMax Vision, and Zea Vision. Speaker’s Bureau: Allergan, Bausch + Lomb Health, Kala Pharmaceuticals, Novartis, Optovue, Sun Pharmaceutical Industries, and Zea Vision. Grant/Research Support: Contamac.
Gloria Chiu, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Avedro/Glaukos and Visionary.
John D. Gelles, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Avedro, Avellino, Boston Sight, Blanchard Labs, Bausch + Lomb, Contamac, Glaukos, Oculus, Synergeyes, and Visionix. Devices: Boston Sight, Blanchard Labs, Oculus, and Ovitz. Grant/Research Support: Avedro, Avellino, Alcon Vision, CorneaGen, Glaukos, Oculus, and Ovitz. Speaker’s Bureau and Advisory Board: Gas Permeable Labs Institute and International Keratoconus Academy.
Andrew S. Morgenstern, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: American Optometric Association. Grant/Research Support: International Keratoconus Academy. Speaker’s Bureau: Alcon Vision, Allergan, Glaukos, and Johnson & Johnson Vision.
All quotes from Dr. Morgenstern are his personal opinion only. It does not reflect the opinion of the US Department of Defense, Defense Health Agency, Department of Veterans Affairs or any other US governmental organization or agency.The Evolve and The Fundingsland Group planners have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group or Avellino.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
